Development of a prognostic model for postoperative survival in appendiceal pseudomyxoma peritonei based on clinical

Jie Jiao1,2, Feng Li3, Qi Liu3

  • 1Department of Gastrointestinal Surgery, Central Hospital Affiliated to Shandong First Medical University, Jinan, China.

Abstract

Insights

Prognosis for appendiceal pseudomyxoma peritonei (PMP) depends on factors like histology and Completeness of Cytoreduction (CC) score. A new dynamic nomogram aids in predicting patient survival post-surgery.

Area of Science:

  • Oncology
  • Surgical Oncology
  • Peritoneal Malignancies

Background:

  • Pseudomyxoma peritonei (PMP) is a rare malignancy originating from appendiceal mucinous neoplasms.
  • Prognosis is influenced by histologic subtype, tumor markers, and completeness of cytoreduction.
  • Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) is the standard treatment.

Purpose of the Study:

  • Identify key factors for long-term prognosis in appendiceal PMP.
  • Develop a dynamic nomogram for postoperative survival prediction.

Main Methods:

  • Retrospective analysis of 153 appendiceal PMP patients.
  • Development of a LASSO-derived inflammation-nutrition score (LINS).
  • Multivariate Cox regression identified prognostic factors: histological type, preoperative PCI, CA125, LINS, and CC score.
  • Nomogram developed and validated for predicting 1-, 3-, and 5-year overall survival (OS).

Main Results:

  • 1-, 3-, and 5-year survival rates were 82.54%, 66.00%, and 56.76%.
  • LINS, CA125, preoperative PCI, histological type, and CC score identified as independent prognostic factors.
  • Nomogram showed good predictive ability (AUCs: 0.945, 0.823, 0.736 at 1, 3, 5 years).
  • A dynamic survival prediction tool is available via Shiny app.

Conclusions:

  • Histological type, preoperative PCI, CA125, LINS, and CC score are independent prognostic factors for appendiceal PMP.
  • The developed nomogram provides accurate survival predictions.
  • The nomogram can be updated for improved clinical decision-making.

Related Concept Videos

Appendicitis-II: Diagnostic Studies and Management01:29

Appendicitis-II: Diagnostic Studies and Management

Diagnosing and managing appendicitis requires a structured and comprehensive approach that spans from initial assessment to postoperative care. Here is an overview of the process:
Diagnosing Appendicitis
It requires a multifaceted approach, starting with a detailed physical examination to pinpoint the location and nature of the pain and identify any associated symptoms. Laboratory tests play a crucial role. A complete Blood Count (CBC) typically reveals leukocytosis (an increased number of...
Appendicitis-I: Introduction01:22

Appendicitis-I: Introduction

The appendix, a small, narrow, blind tube extending from the inferior part of the cecum, is widely regarded as a vestigial organ, having lost much of its original function through evolution. Despite its diminished role, the appendix can become inflamed, a condition known as appendicitis.
Etiology: Appendicitis can arise from various causes, primarily rooted in the obstruction of the appendix lumen. Factors contributing to this obstruction include fecal accumulation, lymphoid hyperplasia and, in...
Appendicitis01:19

Appendicitis

Appendicitis is an acute inflammatory condition of the vermiform appendix, most commonly caused by obstruction of its lumen. The appendix is a narrow, blind-ended pouch that extends from the cecum, making it particularly prone to obstruction. Causes include fecaliths, lymphoid hyperplasia (often after viral infections), parasites, tumors, or foreign bodies. This obstruction initiates a cascade of pathological changes.Luminal Obstruction and Early InflammationAfter obstruction, normal mucosal...
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...